Truist cuts The Trade Desk stock price target to $130
Truist Securities adjusted their outlook on The Trade Desk (NASDAQ:TTD) shares, reducing the price target to $130 from the previous $155 while still maintaining a Buy rating on the company. The ...
Truist maintains Buy on Genmab stock, price target at $50
Truist Securities reiterated their Buy rating on Genmab A/S (NASDAQ:GMAB) with a steady price target of $50.00. The firm's analysts remain confident in the biotech company's prospects, particularly in ...